Confident Investing Starts Here:
- Easily unpack a company's performance with TipRanks' new KPI Data for smart investment decisions
- Receive undervalued, market resilient stocks right to your inbox with TipRanks' Smart Value Newsletter
The latest announcement is out from EMvision Medical Devices Ltd. ( (AU:EMV) ).
EMVision Medical Devices Ltd has received a cash rebate of $2.12 million from the Australian Federal Government’s R&D Tax Incentive Program for the financial year ending June 2024. This rebate reflects the company’s ongoing commitment to research and development, potentially enhancing its financial position and supporting its efforts to bring innovative medical imaging technology to market.
More about EMvision Medical Devices Ltd.
EMVision Medical Devices Ltd operates in the medical device industry, focusing on the development of innovative medical imaging technology. The company’s primary products are designed for non-invasive imaging solutions, targeting the healthcare market.
YTD Price Performance: -3.68%
Average Trading Volume: 29,992
Technical Sentiment Consensus Rating: Buy
Current Market Cap: A$158.2M
Find detailed analytics on EMV stock on TipRanks’ Stock Analysis page.
Trending Articles:
Looking for a trading platform? Check out TipRanks' Best Online Brokers guide, and find the ideal broker for your trades.
Report an Issue